Auro Laboratories Limited (BOM:530233)
India · Delayed Price · Currency is INR 231.10
-3.65 (-1.55%)
At close: Jul 31, 2026
Auro Laboratories Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 35.33 | 18.39 | 77.92 | 24.42 | 28.45 |
Depreciation & Amortization | 28.1 | 10.96 | 10.92 | 10.74 | 10.17 |
Loss (Gain) From Sale of Assets | 2.03 | - | - | - | - |
Other Operating Activities | 53.77 | 1.21 | 35.44 | 20.62 | 16.16 |
Change in Accounts Receivable | 2.43 | 39.99 | -9.88 | 12.09 | -63.14 |
Change in Inventory | -98.72 | 45.72 | 35.16 | -75.01 | -17.08 |
Change in Accounts Payable | -15.38 | 0.09 | -52.75 | 66.18 | -8.87 |
Change in Other Net Operating Assets | 13.57 | -66.15 | 91.26 | -26.22 | -31.58 |
Operating Cash Flow | 21.13 | 50.2 | 188.07 | 32.81 | -65.9 |
Operating Cash Flow Growth | -57.90% | -73.31% | 473.16% | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -571.39 | -238.01 | -356.4 | -40.74 | -46.1 |
Sale of Property, Plant & Equipment | 419.91 | 0.02 | - | - | - |
Investment in Securities | 3.29 | 0.27 | - | - | - |
Other Investing Activities | 0.35 | 0.72 | -30.3 | -10.07 | -7.33 |
Investing Cash Flow | -147.85 | -237 | -386.7 | -50.81 | -53.43 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | 80.63 | 40.63 | 35.42 | - | 113.47 |
Long-Term Debt Issued | 102.28 | 147.07 | 166.2 | 9.09 | - |
Total Debt Issued | 182.91 | 187.71 | 201.61 | 9.09 | 113.47 |
Short-Term Debt Repaid | - | - | -3.31 | -82.73 | -3.07 |
Long-Term Debt Repaid | - | - | - | - | -4.21 |
Total Debt Repaid | - | - | -3.31 | -82.73 | -7.28 |
Net Debt Issued (Repaid) | 182.91 | 187.71 | 198.31 | -73.64 | 106.19 |
Other Financing Activities | -42.53 | -10.83 | -7.36 | -8.14 | -8.26 |
Financing Cash Flow | 140.38 | 176.88 | 190.95 | -81.79 | 97.93 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | -0 | - |
Net Cash Flow | 13.67 | -9.92 | -7.68 | -99.79 | -21.41 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -550.26 | -187.81 | -168.33 | -7.93 | -112 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -179.01% | -98.21% | -31.39% | -1.50% | -22.02% |
Free Cash Flow Per Share | -88.29 | -30.13 | -27.01 | -1.27 | -17.97 |
Levered Free Cash Flow | -618.61 | -194.23 | -226.29 | -43.08 | -100.34 |
Unlevered Free Cash Flow | -593.84 | -187.98 | -222.1 | -38.52 | -96.91 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 39.63 | 10.01 | 6.69 | 7.3 | 8.26 |
Cash Income Tax Paid | - | 7.27 | - | 11.12 | 10.85 |
Change in Working Capital | -98.11 | 19.64 | 63.79 | -22.97 | -120.68 |